Clinical Trial Update: Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin and gemcitabine followed by radiation therapy for Mixed Mullerian Tumors of the Uterus has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Mullerian Tumors of the Uterus

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Mixed Mullerian Tumors of the Uterus | Phase 2 | Status: COMPLETED | Results posted: 2016-04-13